Skip to content

Released May 5, 2025, after the close

10-Q filed May 6, 2025, 36 days after period end · 0001653477-25-000091

Q1 2025 · 10-Q
Revenue$247.90M−27.1% vs Q1 2024+82.8% vs Q4 2024
Net Income$20.50MN/M vs Q1 2024+23.5% vs Q4 2024
EPS Diluted$0.56N/M vs Q1 2024no prior Q4 2024 on file
Gross Profit$111,900,000+12.2%
Operating Cash Flow$25,400,000N/M
Free Cash Flowderived$15,400,000N/M
Margins · derived
Gross margin45.1%+15.8 pt vs Q1 2024
Net margin8.3%+24.7 pt vs Q1 2024

What the release said

The release

Same quarter

MetricQ1 2025Q1 2024Q1 2023Q1 2022
Revenue$247.90M$340.10M$392.60M$382.80M
Net Income$20.50M-$56.00M$50.70M$60.80M
EPS Diluted$0.56-$1.54$1.35$1.55

The same fiscal quarter, prior years. Thaler holds no estimates to compare against.

Ingevity Corp · CIK 1653477 · Engraved from SEC EDGAR